Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001140361-14-034519
Filing Date
2014-09-02
Accepted
2014-09-02 10:28:17
Documents
1

Document Format Files

Seq Description Document Type Size
1 SHANGHAI FOSUN PHARMACEUTICAL (GROUP) CO., LTD SC 13DA 8-25-2014 (NATURE?S SUNSH formsc13da.htm SC 13D/A 32476
  Complete submission text file 0001140361-14-034519.txt   34116
Mailing Address 2500 WEST EXECUTIVE PARKWAY SUITE 100 LEHI UT 84043
Business Address 2500 WEST EXECUTIVE PARKWAY SUITE 100 LEHI UT 84043 (801) 341-7900
NATURES SUNSHINE PRODUCTS INC (Subject) CIK: 0000275053 (see all company filings)

EIN.: 870327982 | State of Incorp.: UT | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-32703 | Film No.: 141076683
SIC: 2834 Pharmaceutical Preparations

Mailing Address 9TH FLOOR, NO.2 EAST FUXING ROAD SHANGHAI F4 200010
Business Address 9TH FLOOR, NO.2 EAST FUXING ROAD SHANGHAI F4 200010 86 21 23138051
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (Filed by) CIK: 0001615258 (see all company filings)

EIN.: 000000000 | State of Incorp.: F4 | Fiscal Year End: 1231
Type: SC 13D/A